{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:31:56Z","timestamp":1790818316872,"version":"4.1.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1097\/dcr.0b013e3182a48505","type":"journal-article","created":{"date-parts":[[2013,11,6]],"date-time":"2013-11-06T14:07:04Z","timestamp":1383746824000},"page":"1423-1433","source":"Crossref","is-referenced-by-count":68,"title":["The Effect of Anti-Tumor Necrosis Factor Alpha Agents on Postoperative Anastomotic Complications in Crohn\u2019s Disease"],"prefix":"10.1097","volume":"56","author":[{"given":"Alaa","family":"El-Hussuna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksander","family":"Krag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Olaison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flemming","family":"Bendtsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise L.","family":"Gluud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-16-20210119","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/SLA.0b013e3181e61df5","article-title":"Trends in surgery for Crohns disease in the era of infliximab.","volume":"252","author":"Jones","year":"2010","journal-title":"Ann Surg"},{"key":"R2-16-20210119","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00384-008-0534-9","article-title":"Intraabdominal septic complications following bowel resection for Crohns disease: detrimental influence on long-term outcome.","volume":"23","author":"Iesalnieks","year":"2008","journal-title":"Int J Colorectal Dis"},{"key":"R3-16-20210119","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"R4-16-20210119","doi-asserted-by":"crossref","first-page":"645","DOI":"10.2165\/00003088-200746080-00002","article-title":"Clinical pharmacokinetics and use of infliximab.","volume":"46","author":"Klotz","year":"2007","journal-title":"Clin Pharmacokinet"},{"key":"R5-16-20210119","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1046\/j.0007-1323.2001.01829.x","article-title":"Systematic review of the definition and measurement of anastomotic leak after gastrointestinal surgery.","volume":"88","author":"Bruce","year":"2001","journal-title":"Br J Surg"},{"key":"R7-16-20210119","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis.","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"R8-16-20210119","first-page":"617","article-title":"Inflximab does not increase the risk of complications in perioperative period in patient with Crohns disease.","volume":"122","author":"Brzezinski","year":"2002","journal-title":"Gastroentrology"},{"key":"R9-16-20210119","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1007\/s10350-008-9364-7","article-title":"Infliximab in ulcerative colitis is associated with an increased risk of postoperative complications after restorative proctocolectomy.","volume":"51","author":"Mor","year":"2008","journal-title":"Dis Colon Rectum"},{"key":"R10-16-20210119","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1007\/s11605-008-0646-0","article-title":"Use of infliximab within 3 months of ileocolonic resection is associated with adverse postoperative outcomes in Crohns patients.","volume":"12","author":"Appau","year":"2008","journal-title":"J Gastrointest Surg"},{"key":"R11-16-20210119","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/j.1572-0241.2004.04148.x","article-title":"Early postoperative complications are not increased in patients with Crohns disease treated perioperatively with infliximab or immunosuppressive therapy.","volume":"99","author":"Colombel","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"R12-16-20210119","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s00268-009-9957-x","article-title":"Effect of perioperative immunosuppressive medication on early outcome in Crohns disease patients.","volume":"33","author":"Indar","year":"2009","journal-title":"World J Surg"},{"key":"R13-16-20210119","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/ibd.21860","article-title":"Infliximab does not affect postoperative complication rates in Crohns patients undergoing abdominal surgery.","volume":"18","author":"Kasparek","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"R14-16-20210119","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1007\/s11605-008-0630-8","article-title":"Perioperative treatment with infliximab in patients with Crohns disease and ulcerative colitis is not associated with an increased rate of postoperative complications.","volume":"12","author":"Kunitake","year":"2008","journal-title":"J Gastrointest Surg"},{"key":"R15-16-20210119","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1365-2036.2004.01904.x","article-title":"The risk of post-operative complications associated with infliximab therapy for Crohns disease: a controlled cohort study.","volume":"19","author":"Marchal","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"R16-16-20210119","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1007\/s11605-010-1341-5","article-title":"Perioperative anti-tumor necrosis factor therapy does not increase the rate of early postoperative complications in Crohns disease.","volume":"14","author":"Nasir","year":"2010","journal-title":"J Gastrointest Surg"},{"key":"R17-16-20210119","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1463-1318.2010.02186.x","article-title":"Short-term outcome of infliximab and other medications on patients with inflammatory bowel disease undergoing ileostomy reversal.","volume":"13","author":"Regadas","year":"2011","journal-title":"Colorectal Dis"},{"key":"R18-16-20210119","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0039-6060(03)00298-8","article-title":"Multivariate analysis suggests improved perioperative outcome in Crohns disease patients receiving immunomodulator therapy after segmental resection andor strictureplasty.","volume":"134","author":"Tay","year":"2003","journal-title":"Surgery"},{"key":"R19-16-20210119","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s00384-011-1236-2","article-title":"Anti-TNF-alpha therapies do not increase early postoperative complications in patients with inflammatory bowel disease. An Italian single-center experience.","volume":"26","author":"Rizzo","year":"2011","journal-title":"Int J Colorectal Dis"},{"key":"R20-16-20210119","doi-asserted-by":"crossref","first-page":"662","DOI":"10.3109\/00365521.2012.660540","article-title":"Biologic treatment or immunomodulation is not associated with postoperative anastomotic complications in abdominal surgery for Crohns disease.","volume":"47","author":"El-Hussuna","year":"2012","journal-title":"Scand J Gastroenterol"},{"key":"R21-16-20210119","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1097\/00054725-201112002-00133","article-title":"AI, Sobrado C. Biological therapy does not increase post operative complications after majorabdominal surgery in crohns disease Brazilian patients.","volume":"17","author":"Kotze","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"R24-16-20210119","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1002\/ibd.22954","article-title":"Anti-tumor necrosis factor and postoperative complications in Crohns disease: systematic review and meta-analysis.","volume":"18","author":"Kopylov","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"R25-16-20210119","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.5114\/aoms.2011.26612","article-title":"A systematic review and meta-analysis of the effects of infliximab on the rate of colectomy and post-operative complications in patients with inflammatory bowel disease.","volume":"7","author":"Ehteshami-Afshar","year":"2011","journal-title":"Arch Med Sci"},{"key":"R26-16-20210119","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/ajg.2009.579","article-title":"The natural history of adult Crohns disease in population-based cohorts.","volume":"105","author":"Peyrin-Biroulet","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"R27-16-20210119","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1136\/gut.2004.045294","article-title":"Impact of the increasing use of immunosuppressants in Crohns disease on the need for intestinal surgery.","volume":"54","author":"Cosnes","year":"2005","journal-title":"Gut"},{"key":"R28-16-20210119","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/DCR.0b013e3182617716","article-title":"Risk factors for postoperative intra-abdominal septic complications after bowel resection in patients with Crohns disease.","volume":"55","author":"Kanazawa","year":"2012","journal-title":"Dis Colon Rectum"}],"container-title":["Diseases of the Colon & Rectum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DCR.0b013e3182a48505","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:14:37Z","timestamp":1620951277000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003453-201312000-00016"}},"subtitle":["a Systematic Review"],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/dcr.0b013e3182a48505","relation":{},"ISSN":["0012-3706"],"issn-type":[{"value":"0012-3706","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}